: Hybridoma Core (Scripps): The responsibilities of the Hybridoma Core are to generate, characterize and maintain monoclonal antibodies for use by all investigators. Specific services include: 1) immunization and bleeding of mice; 2) cell fusion; 3) primary and secondary screening assays (in collaboration with UCSD as needed); 4) cell cloning; 5)ascities fluid production; 6) cell maintenance, freezing and storage; 7) cataloging antibody storage; 8) antibody purification (in collaboration with the UCSD facility); and 9) Immunoglobulin heavy chain identification. Detailed methodologies for each of these techniques have been published previously. More than 250 hybridomas have been generated, cloned, characterized and maintained over the lifetime of this SCOR collaboration, and more than 24 in the last 4 years. Immunology Core (UCSD): The Immunology component at UCSD is responsible for preparation of immunogens used to generate antisera, as well as those used to immunize mice at the Hybridoma Core at Scripps. We use guinea pigs almost exclusively for antisera generation as we have found that they reliably yield high-titered antisera. In fact, we routinely use only 2 guinea pigs per immunization. The Core lab immunizes guinea pigs and determines titers, characterizes the pre- and post-immune antisera, purifies specific immunoglobulins when necessary and stores and catalogues them. Antigens range from isolated apoproteins to fusion proteins to putative receptors, etc. Often such highly purified antisera prove superior even to monoclonal antibodies, for example for cell-injection studies conducted by Drs. Glass, Rosenfeld and colleagues. The UCSD component of the Core also prepares a wide variety of immunological reagents to be used by the other Units, such as primary or, secondary antibodies to be used in immunoassays or Western blots or FACS analysis, and also participates in the purification of antibodies as needed. In addition, the Core will facilitate the selection of polypeptides to be synthesized to make reagent-specific antibodies, which are generated by conjugation to appropriate carriers, such as KLH. For example, we generated peptide-specific antibodies to macrosialin as noted above. During the past four and a half years, we have used 226 guinea pigs to generate antisera to 113 antigens for use by SCOR investigators. We also label antibodies with enzymes, such as alkaline phosphatase or with biotin which can then be used by the different Units for various chemiluminescent assays, Western blots, or for FACS analysis. Finally, an important component of the Immunology Core is to assist investigators and to train new postdoctoral fellows in immunological techniques, both by providing reagents as well as assistance in setting up assays and instructions in use of the chemiluminescent methodologies that we have adapted for all assays. For example, we have utilized commercial reagents for analysis of cytokines, and by use of chemiluminescent techniques greatly increased the sensitivity and linearity of the assays.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
2P50HL056989-06
Application #
6577281
Study Section
Project Start
2002-04-01
Project End
2007-03-31
Budget Start
2002-04-01
Budget End
2003-03-31
Support Year
6
Fiscal Year
2002
Total Cost
$140,945
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Pechlaner, Raimund; Willeit, Peter; Summerer, Monika et al. (2015) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arterioscler Thromb Vasc Biol 35:229-36
Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru et al. (2011) Coronin 2A mediates actin-dependent de-repression of inflammatory response genes. Nature 470:414-8
Wan, Yihong; Evans, Ronald M (2010) Rosiglitazone activation of PPARgamma suppresses fractalkine signaling. J Mol Endocrinol 44:135-42
Chou, Meng-Yun; Fogelstrand, Linda; Hartvigsen, Karsten et al. (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119:1335-49
Bergmark, Claes; Dewan, Asheesh; Orsoni, Alexina et al. (2008) A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 49:2230-9
Liguori, Antonio; D'Armiento, Francesco P; Palagiano, Antonio et al. (2008) Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol 198:281.e1-5
Tsimikas, Sotirios; Aikawa, Masanori; Miller Jr, Francis J et al. (2007) Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. Arterioscler Thromb Vasc Biol 27:175-81
Ricote, Mercedes; Glass, Christopher K (2007) PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771:926-35
Tsimikas, Sotirios; Brilakis, Emmanouil S; Lennon, Ryan J et al. (2007) Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 48:425-33
Palinski, Wulf; Yamashita, Tomoya; Freigang, Stefan et al. (2007) Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev 65:S182-7

Showing the most recent 10 out of 120 publications